Department of Virology, Medical University of Vienna, Vienna, Austria.
Clin Exp Immunol. 2013 Sep;173(3):438-43. doi: 10.1111/cei.12123.
In lung transplant recipients (LTRs), human cytomegalovirus (HCMV) DNAaemia could be associated with HCMV disease and reduced allograft survival. In the present study we analysed whether or not HCMV-specific granzyme B (Grz-B) responses indicating CD8(+) T cell cytotoxicity exert an impact on HCMV DNAaemia and relate to specific interferon (IFN)-γ secretion. HCMV-specific Grz-B responses were quantitated by enzyme-linked immunosorbent assay (ELISA) in 70 samples from 39 HCMV seropositive LTRs who were prospectively investigated for HCMV DNA plasma levels and IFN-γ kinetics using a standardized CD8(+) T cell assay (QuantiFERON®-CMV assay). In all LTRs who were protected from HCMV DNAaemia by early and persistent IFN-γ responses, Grz-B responses were also detected. In LTRs who developed episodes of HCMV DNAaemia, the Grz-B responses which were detected prior to viral DNA detection differed significantly in patients who experienced episodes with high (exceeding 1000 copies/ml) and low plasma DNA levels (P = 0·0290, Fisher's exact test). Furthermore, the extent of Grz-B release prior to viral DNAaemia correlated statistically with the detected levels of IFN-γ (P < 0·0001, Spearman's rank test). Of note, simultaneous detection of Grz-B and IFN-γ secretion was associated significantly with protection from high HCMV DNA plasma levels during the subsequent follow-up (P = 0·0057, Fisher's exact test), and this association was stronger than for IFN-γ detection alone. We conclude that, in addition to IFN-γ responses, Grz-B secretion by CD8(+) T cells is essential to control HCMV replication and a simultaneous measurement of IFN-γ and Grz-B could contribute to the immune monitoring of LTRs.
在肺移植受者(LTR)中,人巨细胞病毒(HCMV)DNA 血症可能与 HCMV 疾病和移植物存活率降低有关。在本研究中,我们分析了 HCMV 特异性颗粒酶 B(Grz-B)反应是否会对 HCMV DNA 血症产生影响,并与特定的干扰素(IFN)-γ分泌有关,这些反应表明 CD8(+)T 细胞的细胞毒性。通过酶联免疫吸附试验(ELISA)在 39 名 HCMV 血清阳性 LTR 的 70 个样本中定量测定了 HCMV 特异性 Grz-B 反应,这些 LTR 前瞻性地调查了 HCMV 血浆水平和 IFN-γ动力学,使用标准化的 CD8(+)T 细胞测定法(QuantiFERON®-CMV 测定法)。在所有通过早期和持续 IFN-γ 反应免受 HCMV DNA 血症保护的 LTR 中,均检测到 Grz-B 反应。在发生 HCMV DNA 血症发作的 LTR 中,在病毒 DNA 检测之前检测到的 Grz-B 反应在经历高(超过 1000 拷贝/ml)和低血浆 DNA 水平的患者中差异显著(P=0.0290,Fisher 精确检验)。此外,病毒 DNA 血症前 Grz-B 释放的程度与检测到的 IFN-γ水平呈统计学相关(P<0.0001,Spearman 秩检验)。值得注意的是,Grz-B 和 IFN-γ 分泌的同时检测与随后随访期间高 HCMV DNA 血浆水平的保护显著相关(P=0.0057,Fisher 精确检验),并且这种相关性强于 IFN-γ 的单独检测。我们得出结论,除了 IFN-γ 反应外,CD8(+)T 细胞的 Grz-B 分泌对于控制 HCMV 复制也是必不可少的,同时测量 IFN-γ 和 Grz-B 可能有助于 LTR 的免疫监测。